Yes, small manufacturers can realistically maintain full GMP compliance, but it requires deliberate prioritization, smart resource allocation, and a clear understanding of which requirements apply to their specific product category and market. GMP compliance is not reserved for large pharmaceutical corporations with dedicated quality departments. Smaller operations can meet regulatory expectations by focusing on the areas that matter most and building lean but effective quality systems. The sections below address the most common questions small manufacturers face when navigating GMP in 2026.
What GMP requirements actually apply to small manufacturers?
The GMP requirements that apply to small manufacturers depend on the type of product, the target market, and the regulatory classification of the product. In the EU, medicinal product manufacturers must comply with EU GMP guidelines regardless of company size. Medical device manufacturers follow ISO 13485 and the EU MDR or IVDR. There are no formal size-based exemptions from GMP compliance obligations.
That said, the scope of applicable requirements is shaped by what you make and where you sell it. A small manufacturer producing a class I medical device faces a significantly different compliance burden than one producing a sterile injectable biologic. The core GMP pillars that apply across most categories include:
- A documented quality management system
- Qualified personnel with defined responsibilities
- Controlled manufacturing processes and procedures
- Equipment qualification and maintenance
- Batch records, traceability, and change control
- Complaint handling and corrective and preventive action (CAPA) processes
Understanding exactly which chapters of EU GMP or which clauses of ISO 13485 apply to your operations is the first step toward building a proportionate compliance program rather than an overwhelming one. If you are unsure where to begin, our GMP and regulatory services are designed to help manufacturers at every stage identify and address the requirements that matter most for their specific situation.
Why do small manufacturers struggle with GMP compliance more than large ones?
Small manufacturers struggle with GMP compliance primarily because the regulatory burden does not scale down with company size. The same documentation requirements, procedural controls, and inspection readiness expectations apply whether a company has 10 employees or 10,000. This creates a disproportionate compliance load for smaller operations with fewer people to absorb it.
Several structural challenges compound this problem. Staff in small companies often wear multiple hats, meaning the same person responsible for production may also be responsible for quality oversight. This creates conflicts of interest and gaps in independent review. Regulatory knowledge is harder to maintain in-house when there is no dedicated regulatory affairs or QA function. Staff turnover also hits harder in small teams because institutional knowledge is concentrated in fewer individuals.
Budget constraints add another layer of difficulty. Validated software systems, qualified laboratory equipment, and external audits all carry significant costs. Large manufacturers spread these costs across high production volumes. For small manufacturers, the fixed cost of compliance infrastructure is a much larger proportion of overall operating expenses.
Which GMP areas are hardest to maintain with limited resources?
The GMP areas that are hardest to maintain with limited resources are training management, change control, supplier qualification, and internal audit programs. These are all process-driven activities that require consistent effort over time rather than a one-time investment, making them vulnerable when staff capacity is stretched.
Training management is frequently underdeveloped in small organizations. Keeping training records current, ensuring retraining after procedure updates, and documenting competency assessments all require ongoing administrative effort that is easy to deprioritize. Change control is similarly demanding. Every change to a process, material, or piece of equipment must be assessed, documented, and approved before implementation, which requires a functioning review structure that small teams often struggle to maintain consistently.
Supplier qualification and ongoing supplier monitoring require dedicated time to audit, review certificates of analysis, and manage qualification documentation. Internal audits are another area where small manufacturers frequently fall short, not because they lack intent, but because finding qualified internal auditors who are independent of the area being audited is genuinely difficult when the team is small.
How can small manufacturers realistically manage GMP without a large QA team?
Small manufacturers can realistically manage GMP compliance without a large QA team by building a lean, risk-based quality system, automating or simplifying documentation where possible, and supplementing internal capacity with external expertise for specialized activities. The goal is a quality system that is fit for purpose rather than one designed for a much larger operation.
Practical approaches that work well for small manufacturers include:
- Risk-based prioritization: Focus the most effort on processes that directly affect product quality and patient safety. Not every procedure requires the same level of control.
- Simplified documentation: Use clear, concise SOPs that are easy to follow and maintain. Overly complex procedures increase the risk of non-compliance, not reduce it.
- Electronic quality management systems: Even lightweight eQMS platforms can automate training reminders, CAPA tracking, and document version control, reducing the administrative burden on small teams.
- External qualified persons and consultants: For activities like internal audits, regulatory submissions, or qualified person oversight, bringing in external expertise on a project basis is often more cost-effective than hiring full-time specialists.
- Cross-training staff: Ensuring more than one person understands each critical GMP function reduces single points of failure and builds organizational resilience.
What happens if a small manufacturer fails a GMP inspection?
If a small manufacturer fails a GMP inspection, the consequences can range from a formal warning letter requiring corrective action to suspension of manufacturing authorization or product recall, depending on the severity of the findings. Regulatory authorities classify inspection findings by risk level, and the response required scales accordingly.
Minor observations typically require a written response with a corrective action plan within a defined timeframe. Major findings require more urgent remediation and may trigger a follow-up inspection to verify corrections. Critical findings, which indicate an immediate risk to product quality or patient safety, can result in the suspension of manufacturing activities or the refusal of marketing authorization applications.
For small manufacturers, the business impact of a failed inspection can be severe. Remediation activities consume resources that are already limited, and any disruption to manufacturing authorization can affect supply commitments and commercial relationships. This is why proactive inspection readiness is a better investment than reactive remediation after an inspection goes wrong. To understand how Starodub approaches inspection readiness for manufacturers of all sizes, visit our company page.
Should small manufacturers handle GMP compliance in-house or outsource it?
Small manufacturers should generally use a hybrid approach: maintain core quality oversight in-house while outsourcing specialized, resource-intensive, or infrequent compliance activities to external experts. Full in-house management is rarely cost-effective at small scale, but complete outsourcing creates dependency and removes the organizational understanding of quality that regulators expect to see embedded in a manufacturer.
Activities that are well-suited to in-house management include day-to-day document control, batch record review, and operational quality oversight. Activities that are often better handled externally include regulatory strategy, specialized audits, qualified person services, and preparation for major regulatory submissions or inspections. External consultants also bring current knowledge of evolving regulatory expectations, which is difficult to maintain internally without dedicated regulatory affairs resources.
The right balance depends on the company’s product portfolio, development stage, and the markets it targets. A company preparing for its first EU GMP inspection has different needs than one maintaining ongoing compliance for an established product line. Get in touch with our team to discuss the approach that best fits your current stage and compliance requirements.
How Starodub supports small manufacturers with GMP compliance
We work with small and growing manufacturers across the biopharmaceutical and medical device sectors to build practical, proportionate GMP compliance programs that hold up under regulatory scrutiny without overwhelming limited internal resources. Our team brings hands-on experience across EU GMP, ISO 13485, and the full range of EU regulatory frameworks, so we understand both what regulators expect and what is realistically achievable at different stages of a company’s growth.
Here is what we can do for your organization:
- GMP gap assessments: We evaluate your current quality system against applicable requirements and identify the highest-priority areas to address before an inspection.
- QMS development and documentation: We help build or improve SOPs, quality manuals, and quality system frameworks that are lean, practical, and compliant.
- Inspection readiness support: We prepare your team for regulatory inspections through mock audits, coaching, and remediation of identified gaps.
- Ongoing regulatory and quality support: Through flexible engagement models, we provide expert oversight for regulatory submissions, change control, and supplier qualification without requiring a full-time hire.
- Quality, Compliance, and Operational Improvements: Our dedicated division, led by Lean Six Sigma Master Black Belts, helps streamline quality processes to reduce the operational burden of compliance on small teams.
If GMP compliance feels like an obstacle rather than a foundation, we can help you change that. Contact us today to discuss how we can support your compliance program with the right level of expertise for your stage and size.
Related Articles
- What is the difference between GMP and cGMP compliance?
- What is the difference between regulatory strategy and regulatory operations?
- How to Write a Clinical Evaluation Report (CER) Under MDR
- ATMP Regulation in Europe: What Developers of Cell and Gene Therapies Need to Know
- What is the ICH guideline?
This content was generated with the help of AI — it may contain mistakes
